Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.55% |
| 2 | Financials | 7.82% |
| 3 | Consumer Discretionary | 7.65% |
| 4 | Communication Services | 5.12% |
| 5 | Healthcare | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NNE
3076
Nano Nuclear Energy
NNE
$1.1B
| $1.01M | ﹤0.01% |
29,314
+11,058
| +61% | +$305K |
|
3077
Sable Offshore Corp
SOC
$773M
| $1.01M | ﹤0.01% |
45,906
-68,020
| -60% | -$1.58M |
|
3078
CALL
Cytokinetics
CYTK
$10.5B
| $1.01M | ﹤0.01% |
30,500
-30,000
| -50% | -$1.04M |
|
3079
Peoples Bancorp
PEBO
$1.48B
| $1M | ﹤0.01% |
32,887
-8,936
| -21% | -$261K |
|
3080
OceanFirst Financial
OCFC
$1.85B
| $1M | ﹤0.01% |
56,952
-15,262
| -21% | -$254K |
|
|
BOEU
3081
Direxion Daily BA Bull 2X ETF
BOEU
$24.2M
| $1M | ﹤0.01% |
+25,000
| New | +$927K |
|
3082
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17.4B
| $1,000K | ﹤0.01% |
11,941
+963
| +9% | +$76.4K |
|
3083
Travere Therapeutics
TVTX
$5.79B
| $1,000K | ﹤0.01% |
67,553
-108,693
| -62% | -$1.8M |
|
3084
National Beverage
FIZZ
$2.9B
| $997K | ﹤0.01% |
23,059
-12,384
| -35% | -$545K |
|
|
SPTN
3085
DELISTED
SpartanNash
SPTN
| $997K | ﹤0.01% |
37,637
-14,816
| -28% | -$296K |
|
3086
Apogee Therapeutics
APGE
$10.2B
| $996K | ﹤0.01% |
22,928
-38,434
| -63% | -$1.46M |
|
3087
Dorian LPG
LPG
$1.91B
| $996K | ﹤0.01% |
40,843
-25,342
| -38% | -$561K |
|
3088
Astronics
ATRO
$4.34B
| $995K | ﹤0.01% |
35,681
+654
| +2% | +$15.3K |
|
|
HSII
3089
DELISTED
Heidrick & Struggles
HSII
| $994K | ﹤0.01% |
21,716
-12,273
| -36% | -$515K |
|
|
3090
PUT
Cytokinetics
CYTK
$10.5B
| $991K | ﹤0.01% |
30,000
-65,500
| -69% | -$2.28M |
|
|
AVDX
3091
DELISTED
AvidXchange
AVDX
| $989K | ﹤0.01% |
101,065
-41,003
| -29% | -$370K |
|
3092
Silvercrest Asset Management
SAMG
$78.6M
| $989K | ﹤0.01% |
62,377
-17,416
| -22% | -$263K |
|
3093
Porch Group
PRCH
$1.83B
| $987K | ﹤0.01% |
83,682
+19,529
| +30% | +$168K |
|
3094
Prudential
PUK
$34.5B
| $982K | ﹤0.01% |
39,238
+29,387
| +298% | +$657K |
|
3095
Macy's
M
$6.26B
| $982K | ﹤0.01% |
84,192
-87,321
| -51% | -$1.01M |
|
3096
PUT
Super Micro Computer
SMCI
$25.3B
| $980K | ﹤0.01% |
20,000
-79,900
| -80% | -$3.08M |
|
3097
American Superconductor
AMSC
$1.56B
| $980K | ﹤0.01% |
26,706
-494
| -2% | -$12.1K |
|
3098
PUT
Fidelity National Information Services
FIS
$22.8B
| $977K | ﹤0.01% |
+12,000
| New | +$934K |
|
|
ARDT
3099
Ardent Health
ARDT
$1.57B
| $974K | ﹤0.01% |
71,307
+54,471
| +324% | +$733K |
|
3100
Reynolds Consumer Products
REYN
$5.53B
| $973K | ﹤0.01% |
45,440
-7,862
| -15% | -$178K |
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup withdrew a net $14.6B in Q2 2025, closing 377 positions and reducing 2,974 holdings. Its most notable exit was James Hardie Industries, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Amrize Ltd worth $114M.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 468 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.